Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.

Moxalactam (LY127935) exhibited greater in vitro activity than cefamandole and tobramycin against clinical isolates of Enterobacteriaceae, Aeromonas hydrophila, and Pseudomonas maltophilia. The activities of the three drugs against other microorganisms were as follows: for staphylococci, cefamandole...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Antimicrob Agents Chemother
Main Authors: Jones, R N, Fuchs, P C, Sommers, H M, Gavan, T L, Barry, A L, Gerlach, E H
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology (ASM) 1980
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283866/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6446880/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.17.4.750
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker